Inotuzumab ozogamicin injection (vial) used to treat certain types of leukemia
Contains inotuzumab ozogamicin 0.9mg, an antibody-drug conjugate that targets and destroys cancerous B-cells, used to treat relapsed or refractory B-cell acute lymphoblastic leukemia.
Attributes
Product Content
How to Use:
• Administered only by a doctor or nurse by intravenous infusion in a hospital setting.
• Dose and schedule are decided by your oncologist.
• Regular blood tests and liver monitoring are needed.
• Prescription medicine; take exactly as prescribed and consult your doctor before use.
The link to Besponsa 0.9mg 1 Vial (Refregirated) has been copied